Date(s) of inspection:
- August 2023
Aim of inspection
The purpose of the inspection was to review compliance of Musgrove Park Hospital’s arrangements for class 7 radioactive material for road transport, covering consignor duties.
Subject(s) of inspection
- Transport (Non-nuclear) Appropriate management system – Rating: Green
- Transport (Non-nuclear) Contingency plans in accordance with IRR Reg 13 – Rating: Amber
- Transport (Non-nuclear) Dangerous Goods Safety Advisor subsection 1.8.3 ADR – Rating: Green
- Transport (Non-nuclear) Radiation Protection Adviser Reg 14 IRR17 – Rating: Green
- Transport (Non-nuclear) Radiation Risk Assessment Reg 8 of IRR 17 – Rating: Amber
- Transport (Non-nuclear) Training – Rating: Green
- Transport (Non-nuclear) Transport documentation – Rating: Green
Key findings, inspector’s opinions and reasons for judgement made
The inspector reviewed a range of topics and identified a number of examples of Musgrove Park Hospital meeting relevant good practice in reducing risk to levels that are ALARP, including appropriate appointment of Safety Advisers and Radiation Protection Supervisors, the provision of appropriate Radiation Protection Supervisor training, an appropriate Safety Advisers annual report and a valid certificate of compliance for the transport package used.
The inspector identified three areas of non-compliance and discussed these during the inspection. These were associated with required improvements to the hospital’s transport radiation risk assessment, emergency arrangements and consignor’s certificate.
The inspection findings were presented to Musgrove Park Hospital at the close of the inspection.
I judged an overall inspection rating of ‘Green – no formal action’ was appropriate for this inspection.
Musgrove Park Hospital is required to provide ONR either with evidence that the three identified non-compliances have been resolved, or an appropriate resolution plan with timescales for completion, by the 29 September 2023. The non-compliances will be tracked to completion via a level 4 regulatory issue.